// App-Quantinova.ai

2347 : The amphiphatic (2,2)-amino acid derivative, LTX-401 induces complete regression of experimental hepatocellular carcinomas

Researchers

Presenter

  • Brynjar Mauseth

Principal Investigators

  • Ji-Hua Shi

  • Ketil Camilio

  • ystein Rekdal

  • Baldur Sveinbjrnsson

  • Pal-Dag Line

Medical Centers

  • Institute of Medical Biology, University of Troms, TROMS, Norway

  • Division of Cancer, Surgery and Transplantation, Oslo University Hospital, OSLO, Norway.

  • Lytix Biopharma AS, Oslo, Norway

  • Institute of Pathology, Oslo University Hospital, Oslo, Norway.

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

  • Advanced refractory tumors

Biomarkers

  • High Mobility Group Box 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved